Literature DB >> 14589222

Microscopic lumbar discectomy results for 60 cases in professional and Olympic athletes.

Robert G Watkins1, Lytton A Williams, Robert G Watkins1.   

Abstract

BACKGROUND CONTEXT: There is no documented information indicating time for return to play after lumbar discectomy in professional and Olympic athletes.
PURPOSE: To determine the rate of return to sport and the average time of recovery in elite athletes undergoing microscopic lumbar discectomy (MLD). STUDY
DESIGN: Between 1984 and 1998, the senior author performed 60 MLDs on 59 professional and Olympic athletes with lumbar herniated nucleus pulposus. PATIENT SAMPLE: Sixty consecutive MLDs performed on professional and Olympic athletes were reviewed. OUTCOME MEASURES: The rate of return and the average time to return to sport were determined. Also, the distribution of pain and presence of neurologic deficits were recorded.
METHODS: A retrospective review was performed.
RESULTS: Follow-up indicated that all but 7 of the 60 cases had returned to their sport, including one who underwent a second MLD for a herniation at an adjacent level. The average time from surgery to return was 5.2 months for the entire group, with a range of 1 to 15 months.
CONCLUSION: MLD was effective in correcting the problems that forced the athletes to seek help, and the time to return often depends on factors other than their medical condition. Postoperatively, a complete trunk stabilization rehabilitation program was effective in returning these athletes to a high level of competition.

Entities:  

Mesh:

Year:  2003        PMID: 14589222     DOI: 10.1016/s1529-9430(02)00569-7

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  9 in total

Review 1.  Intervertebral disc herniation in elite athletes.

Authors:  Jonathan T Yamaguchi; Wellington K Hsu
Journal:  Int Orthop       Date:  2018-12-01       Impact factor: 3.075

Review 2.  The development of an evidence-based patient booklet for patients undergoing lumbar discectomy and un-instrumented decompression.

Authors:  A H McGregor; A K Burton; P Sell; G Waddell
Journal:  Eur Spine J       Date:  2006-05-11       Impact factor: 3.134

Review 3.  Outcomes of Lumbar Discectomy in Elite Athletes: The Need for High-level Evidence.

Authors:  Rueben Nair; Cynthia A Kahlenberg; Wellington K Hsu
Journal:  Clin Orthop Relat Res       Date:  2015-06       Impact factor: 4.176

4.  Return to play in professional baseball players following transforaminal endoscopic decompressive spine surgery under local anesthesia.

Authors:  Toru Maeda; Nobutoshi Takamatsu; Ayaka Hashimoto; Yasuyuki Omichi; Kosuke Sugiura; Yoshihiro Ishihama; Hiroaki Manabe; Kazuta Yamashita; Yoichiro Takata; Toshinori Sakai; Koichi Sairyo
Journal:  J Spine Surg       Date:  2020-01

5.  Assessment of Outcomes of Spine Surgery in Indian Athletes Involved in High-End Contact Sports.

Authors:  Kunal Shah; Anuj Bharuka; Akshay Gadiya; Abhay Nene
Journal:  Asian Spine J       Date:  2020-06-12

6.  Outcomes of Various Treatment Modalities for Lumbar Spinal Ailments in Elite Athletes: A Literature Review.

Authors:  Akshay Gadia; Kunal Shah; Abhay Nene
Journal:  Asian Spine J       Date:  2018-07-27

7.  "Fantasy Points" associated with Professional Athlete Performance after Lumbar Discectomy or Microdiscectomy.

Authors:  Marvin Kajy; Devan O Higginbotham; Guy Ball; Rahul Vaidya
Journal:  Spartan Med Res J       Date:  2022-02-24

8.  Return to play after conservative treatment in athletes with symptomatic lumbar disc herniation: a practice-based observational study.

Authors:  Jun Iwamoto; Yoshihiro Sato; Tsuyoshi Takeda; Hideo Matsumoto
Journal:  Open Access J Sports Med       Date:  2011-03-18

9.  Return to Play After Symptomatic Lumbar Disc Herniation in Elite Athletes: A Systematic Review and Meta-analysis of Operative Versus Nonoperative Treatment.

Authors:  Phelopater Sedrak; Mustafa Shahbaz; Chetan Gohal; Kim Madden; Ilyas Aleem; Moin Khan
Journal:  Sports Health       Date:  2021-02-10       Impact factor: 3.843

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.